权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Bioinspired Synthetic Grafts for Bone Regeneration

用于骨再生的仿生合成移植物

基本信息

批准号：
9551215
负责人：
Shyni Varghese
金额：
$ 34.8万
依托单位：
DUKE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-09-01 至 2019-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9551215
关键词：
Adenosine Adverse effects Allografting Area Autologous Transplantation BMP2 gene Biocompatible Materials Biological Models Biomimetics Blood Blood Vessels Bone Regeneration Bone Tissue Bone Transplantation CXCR4 Receptors Calcified Calcinosis Calcium Cell physiology Cells Clinical Cues Defect Development Environment Exhibits Extracellular Matrix Failure Gene Expression Glycerol Goals Growth Factor Heterogeneity Histology Homeostasis Human Implant In Vitro Ions Laboratories Lateral Manuals Measures Mechanics Mediating Membrane Proteins Minerals Molecular Molecular Profiling Morbidity - disease rate Natural regeneration Osteoblasts Osteogenesis Palpation Performance Phase Play Polymers Property Proteins Recruitment Activity Regenerative Medicine Research Roentgen Rays Role Side Signal Transduction Site Stem cells Structure System Therapeutic Time Tissues Transplanted tissue Undifferentiated Vascular Endothelial Growth Factors Vascularization base biomineralization bone calcification calcium phosphate cost cost effective design disease transmission drug development in vivo infancy inorganic phosphate insight osteogenic programs public health relevance repaired sham surgery stem cell differentiation success tissue regeneration tissue repair

项目摘要

DESCRIPTION (provided by applicant): Synthetic systems that provide structural support while activating endogenous cells to form functional bone tissues have been considered as an optimal therapeutic strategy for treating critical bone defects. Currently, autografts and allografs are the primary choice of implants, but both suffer from various drawbacks such as donor site morbidity, scarcity, immunorejection, or disease transmission. In contrast, synthetic bone grafts with intrinsic osteoinductivity and osteogenicity could provide an easy-to-manufacture, cost-effective, and widely available therapeutic strategy for treating bone defects/failures. In the proposed study, we will investigate the efficacy of a fully synthetic bone grafts being developed in our laboratory to form in vitro and in vivo bone tissues. The biomimetic bone graft described here is developed by using principles of biomineralization, which leads to formation of a synthetic bone-like extracellular matrix that recapitulates various static and dynamic physicochemical cues of the native tissue including the dynamic dissolution/formation of mineral phase. Using this graft, we will: (1) determine the role of various physicochemical cues from the matrix and the mineral environment on osteogenic differentiation of stem cells in vitro, (2) elucidate the mechanism by which the biomineralized grafts exhibits osteogenicity and osteoinductivity, and (3) in vivo bone formation ability of the grafts by using posterolateral fusin as a model system. The grafts are designed to provide the structural and mechanical integrity required for bone grafting, while activating endogenous cells to promote bone formation. Such an endogenous cell-driven strategy in regenerative medicine has the potential to circumvent the limitations of existing approaches associated with cost, space, and time. Such an approach involving synthetic grafts devoid of any growth factors will also confine the bone formation to the implant site and overcome major side effects associated with growth factor-containing grafts. Though the proposed study is focused on bone tissue formation and repair, the biomimetic approach can be applied to study other cells/systems, thus having a far-reaching impact.

描述（由申请人提供）：提供结构支撑同时激活内源细胞形成功能性骨组织的合成系统已被认为是治疗严重骨缺陷的最佳治疗策略。目前，自体移植物和同种异体移植物是植入物的主要选择，但两者都存在各种缺点，例如供体部位发病率、稀缺性、免疫排斥或疾病传播。相比之下，具有内在骨诱导性和成骨性的合成骨移植物可以为治疗骨缺陷/失败提供一种易于制造、具有成本效益且广泛可用的治疗策略。在拟议的研究中，我们将研究我们实验室开发的全合成骨移植物在体外和体内形成骨组织的功效。这里描述的仿生骨移植物是利用生物矿化原理开发的，这导致合成骨样细胞外基质的形成，该基质概括了天然组织的各种静态和动态物理化学线索，包括矿物相的动态溶解/形成。使用该移植物，我们将：（1）确定来自基质和矿物质环境的各种物理化学线索对干细胞体外成骨分化的作用，（2）阐明生物矿化移植物表现出成骨性和骨诱导性的机制，以及（3）使用后外侧融合蛋白作为模型系统，移植物的体内骨形成能力。移植物旨在提供骨移植所需的结构和机械完整性，同时激活内源细胞以促进骨形成。再生医学中的这种内源细胞驱动策略有可能克服现有方法在成本、空间和时间方面的局限性。这种涉及不含任何生长因子的合成移植物的方法也将骨形成限制在植入部位并克服与含生长因子移植物相关的主要副作用。虽然拟议的研究重点是骨组织的形成和修复，但仿生方法可以应用于研究其他细胞/系统，从而产生深远的影响。